DexCom (DXCM) Tops Q4 EPS by 7c; offers guidance

DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.50, $0.07 better than the analyst estimate of $0.43. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $1.02 billion.

GUIDANCE:

DexCom sees FY2024 revenue of $4.15-4.35 billion, versus the consensus of $4.33 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BofA maintains underperform ratings on six BDC stocks
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand